The Pharmaletter

One To Watch

eterna-tx-company

Eterna Therapeutics

A life science company researching mRNA cell engineering to create new medicines.

Eterna has in-licensed a portfolio of over 130 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system from Factor Bioscience.

Want to Update your Company's Profile?


Latest Eterna Therapeutics News

More Eterna Therapeutics news >